Newswise — The National Inhalant Prevention Coalition, with support from the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA), will hold a press conference March 17 to discuss disturbing new government data about the public health problem of inhalant abuse by adults. The event will feature:

WHO: H. Westley Clark, M.D., M.P.H., Director, Center for Substance Abuse Treatment, SAMHSA

Gil Kerlikowske, Director, Office of National Drug Control Policy 

Harvey Weiss, Executive Director, National Inhalant Prevention Coalition

David Shurtleff, Ph.D., Acting Deputy Director, National Institute on Drug Abuse, NIH

Howard C. Wolfe, MA, LMFT, an inhalant expert and director of the New England Inhalant Abuse Coalition 

Jennifer N. Caudle, D.O., an osteopathic family physician from Ypsilanti, Michigan, representing the American Osteopathic Association.

Erin Davis, a 42 year-old woman in recovery from addiction to inhalants, from Centerville, Ohio, outside of Dayton.

WHEN: March 17, 2011 at 9:30 A.M.

WHERE: National Press Club

                Holman Lounge

                14th and F Streets, NW

                Washington, D.C.

                Metro: Metro Center

 

 SAMHSA is a public health agency within the Department of Health and Human Services. Its mission is to reduce the impact of substance abuse and mental illness on America’s communities.

 

MEDIA CONTACT
Register for reporter access to contact details